Sign Up Today and Learn More About Splice Bio Stock
Invest in or calculate the value of your shares in Splice Bio or other pre-IPO companies through EquityZen's platform.
Splice Bio Stock
Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.
About Splice Bio Stock
Founded
2012
Industries
Software, Artificial Intelligence, Data and Analytics
Splice Bio Press Mentions
Stay in the know about the latest news on Splice Bio
Series B brings Splicebio $135M for Stargardt disease asset
bioworld • Jun 13, 2025
SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines
pharmiweb • Jun 12, 2025
SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines
prnewswire • Jun 12, 2025
SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines
prnewswire • Jun 11, 2025
EQT Life Sciences Co-Leads USD 135 Million Series B Financing in SpliceBio
prnewswire • Jun 11, 2025
Splice Bio Management
Leadership team at Splice Bio
Board Member
Erica Whittaker
Board Member
Marc Montserrat
Join now and verify your accreditation status to gain access to:
- Splice Bio Current Valuation
- Splice Bio Stock Price
- Splice Bio Management
- Available deals in Splice Bio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Splice Bio Cap Table and Funding History by Share Class and Liquidity Preferences
- Splice Bio Revenue and Financials
- Splice Bio Highlights
- Splice Bio Business Model
- Splice Bio Risk Factors
- Splice Bio Research Report from SACRA Research
Trading Splice Bio Stock
How to invest in Splice Bio stock?
Accredited investors can buy pre-IPO stock in companies like Splice Bio through EquityZen funds. These investments are made available by existing Splice Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Splice Bio stock?
Shareholders can sell their Splice Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."